| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Herlev Hospital |
| Information provided by: | Herlev Hospital |
| ClinicalTrials.gov Identifier: | NCT00197847 |
Purpose
Purpose of the study is to investigate and quantify known and possible new riskfactors for nosocomiel infection and death in the intensive care setting.
As new riskfactors Mannose Binding Lechtin and Procalcitonin are chosen and compared to established riskfactors.
| Condition |
|
Infection Pneumonia Sepsis Cross Infection |
| MedlinePlus related topics: | Pneumonia Sepsis |
| Study Type: | Observational |
| Study Design: | Natural History, Longitudinal, Defined Population, Prospective Study |
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:Admission to ICU -
Exclusion Criteria:Absence of informed consent and age less than 18 years
-
Contacts and Locations| Denmark, Copenhagen Couty | |||||
| Department of Intensive Care | |||||
| Copenhagen, Copenhagen Couty, Denmark, DK-2730 | |||||
| Herlev Hospital |
| Principal Investigator: | Dorthe H Olsen, M.D. | Department of Intensive Care, Herlev University Hospital |
More Information
| Study ID Numbers: | KA 02071 |
| First Received: | September 12, 2005 |
| Last Updated: | September 12, 2005 |
| ClinicalTrials.gov Identifier: | NCT00197847 |
| Health Authority: | Denmark: The Regional Committee on Biomedical Research Ethics |
|
|
|
|
